South African Medical Journal (Jul 2024)

Missed rifampicin and isoniazid resistance by commercial molecular assays

  • L Richards,
  • F Ismail,
  • J Nel,
  • S V Omar

DOI
https://doi.org/10.7196/SAMJ.2024.v114i17.1779
Journal volume & issue
Vol. 114, no. 7

Abstract

Read online

Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed by molecular testing and were only identified by phenotypic testing.

Keywords